PAVM News and Press, PAVmed Inc. From 04/09/21

PAVmed Inc. (NASDAQ:PAVM) traded at a new 52-week high today of $5.94. So far today approximately 2.4 million shares have been exchanged, as compared to an average 30-day volume of 5 million shares. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technol...

NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman...

Gainers: Brooklyn ImmunoTherapeutics (BTX) +45%, Greenwich LifeSciences (GLSI) +16%, PAVmed (PAVM) +15%, SeaSpine Holdings (SPNE) +14%, Cara Therapeutics (CARA) +14%.Losers: Scholar Rock (SRRK) -14%, Chembio Diagnostics (CEMI) -13%, Harmo...

Gainers: Universe Pharmaceuticals UPC +50%, Applied Molecular Transport AMTI +26%, Sonoma Pharmaceuticals (SNOA) +17%, United Therapeutics UTHR +16%, PAVmed (PAVM) +12%.Losers: AzurRx BioPharma (AZRX) -28%, BioXcel Therapeutics (BTAI) -14%,&#x...

Does Your List Of Robinhood Penny Stocks Have These On It? Penny stocks are some of the highest risk investment classes in the stock market today. Yet they remain sought after by day traders and investors alike. The short-term prospects entail high-flying shares, turning a big profit qu...

The tech selloff so far has been brutal and quick, with 5% to 10% moves daily in high growth names across the board. On February 23rd I published a list of my picks to buy on weakness and I acted on it, in some cases it appears too early. Below I list which companies I purchased d...

PAVmed has significant room to grow in the next year with their extensive pipeline for a range of clinical conditions, with an addressable market of over $3 billion. The company has recognizable and successful management led by Lishan Aklog, with the recent addition of Stanley Lapidus...

NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has retired all of the Company’s outst...

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the Advanced Medical Technology Association ...

PAVmed ([[PAVM]] -6.2%)  announces the closing of its previously announced underwritten public offering of about 9.8M shares of with gross proceeds of about $45M.PAVmed intends to use the net proceeds from the offering to repay all of the company’s outstanding debt, including...